Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an update.
EZZ Life Science Holdings has notified the market of the cessation of several classes of securities, with 10,000 performance rights and a total of 130,000 ordinary fully paid shares lapsing after the conditions attached to those securities were not met or became incapable of being satisfied between October 2025 and early January 2026. The lapses reduce potential future dilution from these conditional equity instruments and slightly adjust the company’s issued capital profile, but do not reflect any change in its core operations, instead signalling that certain performance or vesting hurdles tied to those securities were not achieved.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is an Australia-listed life sciences company (ASX: EZZ) operating in the health and wellness sector, with its capital structure including ordinary fully paid shares and performance rights traded on the ASX.
Average Trading Volume: 70,781
Technical Sentiment Signal: Sell
Current Market Cap: A$65.57M
See more insights into EZZ stock on TipRanks’ Stock Analysis page.